Deerfield Management Company, L.P.

Institutional investor · Portfolio as of Q3 2022

Q3 2022 biggest moves
  • VTRSVTRS

    Viatris

    Cut 48%

    now 1.8% of portfolio

  • BIIBBIIB

    Biogen

    Closed calls

    on 500K shares

  • CPRXCPRX

    CATALYST PHARMACEUTICALS

    New

    1.3% of portfolio

  • AHCOAHCO

    AdaptHealth

    Cut 26%

    now 3.1% of portfolio

78 changes in all

Top Holdings131 positions

Checking export access…
Activity:
NUVL
NUVLDelisted

NUVALENT INC

19.3M$376M7.5%——
5 qtrssince 2021-Q3
Unchanged
0
??
GLAUKOS CORPDelisted
Bond
271.8M$355.8M7.1%——
6 qtrssince 2021-Q2
Unchanged
0
174.4M$170.8M3.4%——
9 qtrssince 2020-Q3
Increased
62
??
INVITAE CORPDelisted
Bond
206.9M$162.2M3.2%——
9 qtrssince 2020-Q3
Unchanged
0
NBIX

Neurocrine Biosciences, Inc.

1.5M$160.7M3.2%$95.11+11.67%
7 qtrssince 2021-Q1
Decreased
0
AHCO

AdaptHealth Corp.

8.2M$154.4M3.1%$23.56-20.30%
12 qtrssince 2019-Q4
Decreased
0
88.7M$148.3M3.0%——
3 qtrssince 2022-Q1
Unchanged
0
127.8M$128.5M2.6%——
2 qtrssince 2022-Q2
Unchanged
0
144.5M$115.5M2.3%——
7 qtrssince 2021-Q1
Unchanged
0
SILK
SILKDelisted

SILK ROAD MEDICAL INC

2.5M$114.1M2.3%——
8 qtrssince 2020-Q4
Decreased
0
??
CAREMAX INCDelisted
15.9M$112.5M2.2%——
6 qtrssince 2021-Q2
Unchanged
0
51.9M$99.1M2.0%——
9 qtrssince 2020-Q3
Unchanged
0
GILD

Gilead Sciences, Inc.

1.5M$94.9M1.9%$52.26+3.49%
3 qtrssince 2022-Q1
Decreased
0
??
NUVASIVE INCDelisted
Bond
97M$93.7M1.9%——
6 qtrssince 2021-Q2
Unchanged
0
VTRS

Viatris Inc.

10.7M$90.9M1.8%$14.06-48.95%
8 qtrssince 2020-Q4
Decreased
0
BIIB

Biogen Inc.

330,000$88.1M1.8%$267.000.00%
1 qtr
New
68
??
ALPHATEC HLDGS INCDelisted
Bond
100M$81.4M1.6%——
1 qtr
New
68
78.5M$81.1M1.6%——
1 qtr
New
68
81.6M$80.8M1.6%——
5 qtrssince 2021-Q3
Unchanged
0
??
ACCOLADE INCDelisted
Bond
105M$79.1M1.6%——
2 qtrssince 2022-Q2
Increased
53
$5B
AUM
131
Positions
Q3 2022
Filing
HI rating · 1.0/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2021-Q2$5,629,668,00018.3114717407%
2021-Q3$5,123,921,000-8.98360258545%
2021-Q4$4,767,581,000-6.95443977376%
2022-Q1$4,472,946,000-6.17996841585%
2022-Q2$4,848,381,0008.39346149048%
2022-Q3$5,023,740,0003.61685684355%
Activity profile
$ moved · Q3'22
New30%Increased15%Decreased30%Exited26%
Composition
Equity vs derivatives
Equity>99%Puts0%Calls<1%
Holding period
Avg 1.5 years
<1Q9%1-4Q16%1-2Y40%2Y+34%

Deerfield Management Company, L.P. manages $5B across 131 positions as of Q3 2022. Top holdings: NUVL (7.5%), GLAUKOS CORP (7.1%), AERIE PHARMACEUTICALS INC (3.4%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1/5.0.

Top holdings by portfolio weight

Total AUM$5B
NUVL7.48%
GLAUKOS CORP7.08%
AERIE PHARMA3.40%
INVITAE CORP3.23%
NBIX3.20%
AHCO3.07%
SAREPTA THER2.95%
IONIS PHARMA2.56%
TABULA RASA 2.30%
SILK2.27%
Other2.24%

Portfolio allocation by GICS sector

Sectors2
Healthcare74.30%
Unknown25.70%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L32
Conviction55
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
BCRXBCRXBioCryst Pharmaceuticals, Inc.
Q3 2025 → Q3 2026+10.8M shares+$87M
3Q
TNGXTNGXTango Therapeutics, Inc.
Q1 2026 → Q3 2026+2.3M shares+$103.5M
2Q
BMRNBMRNBioMarin Pharmaceutical Inc.
Q2 2026 → Q3 2026+1.2M shares+$73.4M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used